File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Mid-term outcomes of concomitant left atrial appendage closure and catheter ablation for non-valvular atrial fibrillation: a multicenter registry.

TitleMid-term outcomes of concomitant left atrial appendage closure and catheter ablation for non-valvular atrial fibrillation: a multicenter registry.
Authors
KeywordsAtrial fibrillation
Left atrial appendage closure
Catheter ablation
Concomitant
Issue Date2019
PublisherSpringer Japan. The Journal's web site is located at www.springerlink.com/openurl.asp?genre=journal&issn=0910-8327
Citation
Heart and Vessels, 2019, v. 34 n. 5, p. 860-867 How to Cite?
AbstractTo investigate the safety and midterm outcome of concomitant left atrial appendage (LAA) closure and catheter ablation (CA) as a one-stage hybrid procedure for non-valvular atrial fibrillation (AF) in a multicenter registry. A total of 50 consecutive patients with symptomatic drug-resistant non-valvular AF with CHA(2)DS(2)-VASc score 2 and contraindications for antithrombotic therapy were included in the prospectively established LAA closure registry, and underwent concomitant LAA closure (48 for WATCHMAN and 2 for ACP) and CA procedure (40 for radiofrequency and 10 for cryoballoon CA). Two cardiac tamponades, one peripheral vascular complications and one mild air embolism were observed during perioperative period. After mean follow-up of 20.2 +/- 11.5months, 18 (36%) patients presented with atrial arrhythmia relapse and 45 (91.8%) patients presented with complete sealing; furthermore, there were two transient ischemic attacks and one ischemic stroke under an off-oral anticoagulant situation, respectively. Concomitant CA and LAA closure as a one-stage hybrid procedure might be feasible and potentially decrease costs in patients with symptomatic non-valvular AF with high stroke risk and contraindication to antithrombotic treatment, and as safe as LAA closure procedure only during the perioperative period. However, it was necessary to further validate the mid-term safety.
Persistent Identifierhttp://hdl.handle.net/10722/275119
ISSN
2023 Impact Factor: 1.4
2023 SCImago Journal Rankings: 0.574
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorLiu, FZ-
dc.contributor.authorLin, WD-
dc.contributor.authorLiao, HT-
dc.contributor.authorPeng, J-
dc.contributor.authorXue, YM-
dc.contributor.authorZhan, XZ-
dc.contributor.authorZhu, JM-
dc.contributor.authorYiu, KH-
dc.contributor.authorLi, YF-
dc.contributor.authorTse, HF-
dc.contributor.authorShi, L-
dc.contributor.authorFang, XH-
dc.contributor.authorWu, SL-
dc.date.accessioned2019-09-10T02:35:50Z-
dc.date.available2019-09-10T02:35:50Z-
dc.date.issued2019-
dc.identifier.citationHeart and Vessels, 2019, v. 34 n. 5, p. 860-867-
dc.identifier.issn0910-8327-
dc.identifier.urihttp://hdl.handle.net/10722/275119-
dc.description.abstractTo investigate the safety and midterm outcome of concomitant left atrial appendage (LAA) closure and catheter ablation (CA) as a one-stage hybrid procedure for non-valvular atrial fibrillation (AF) in a multicenter registry. A total of 50 consecutive patients with symptomatic drug-resistant non-valvular AF with CHA(2)DS(2)-VASc score 2 and contraindications for antithrombotic therapy were included in the prospectively established LAA closure registry, and underwent concomitant LAA closure (48 for WATCHMAN and 2 for ACP) and CA procedure (40 for radiofrequency and 10 for cryoballoon CA). Two cardiac tamponades, one peripheral vascular complications and one mild air embolism were observed during perioperative period. After mean follow-up of 20.2 +/- 11.5months, 18 (36%) patients presented with atrial arrhythmia relapse and 45 (91.8%) patients presented with complete sealing; furthermore, there were two transient ischemic attacks and one ischemic stroke under an off-oral anticoagulant situation, respectively. Concomitant CA and LAA closure as a one-stage hybrid procedure might be feasible and potentially decrease costs in patients with symptomatic non-valvular AF with high stroke risk and contraindication to antithrombotic treatment, and as safe as LAA closure procedure only during the perioperative period. However, it was necessary to further validate the mid-term safety.-
dc.languageeng-
dc.publisherSpringer Japan. The Journal's web site is located at www.springerlink.com/openurl.asp?genre=journal&issn=0910-8327-
dc.relation.ispartofHeart and Vessels-
dc.rightsThis is a post-peer-review, pre-copyedit version of an article published in [insert journal title]. The final authenticated version is available online at: http://dx.doi.org/[insert DOI]-
dc.subjectAtrial fibrillation-
dc.subjectLeft atrial appendage closure-
dc.subjectCatheter ablation-
dc.subjectConcomitant-
dc.titleMid-term outcomes of concomitant left atrial appendage closure and catheter ablation for non-valvular atrial fibrillation: a multicenter registry.-
dc.typeArticle-
dc.identifier.emailYiu, KH: khkyiu@hku.hk-
dc.identifier.emailTse, HF: hftse@hkucc.hku.hk-
dc.identifier.authorityYiu, KH=rp01490-
dc.identifier.authorityTse, HF=rp00428-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1007/s00380-018-1312-4-
dc.identifier.pmid30599061-
dc.identifier.scopuseid_2-s2.0-85059308383-
dc.identifier.hkuros304620-
dc.identifier.volume34-
dc.identifier.issue5-
dc.identifier.spage860-
dc.identifier.epage867-
dc.identifier.isiWOS:000464886600016-
dc.publisher.placeJapan-
dc.identifier.issnl0910-8327-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats